03 September 2023 : Clinical Research
Association Between Fatty Liver Index, Controlled Attenuation Parameter, and Metabolic Syndrome Stages: A Community-Based Study
Lee Won Chong12BDEG, Bagas Suryo Bintoro34CDEF, Ming-Hsien Tsai25DF, Yu-Min Lin12DF, Chyi-Huey Bai67ABCEG*DOI: 10.12659/MSM.940691
Med Sci Monit 2023; 29:e940691
Table 3 The association of fatty liver index and controlled attenuation parameters with metabolic syndrome stage using ordered logistic regression.
| Metabolic syndrome stages (A, B, and [C+D])# | ||||||
|---|---|---|---|---|---|---|
| Crude | Model 1 | Model 2 | ||||
| Predictor | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) |
| FLI (every 1 quartile) | 2.83 | (2.09–3.84) | 3.1 | (2.23–4.31) | 3.1 | (2.23–4.32) |
| CAP (every 1 quartile) | 1.86 | (1.42–2.43) | 1.96 | (1.49–2.59) | 1.96 | (1.48–2.59) |
| FLI (every 1 quartile) | 3.64 | (2.35–5.63) | 3.28 | (2.11–5.11) | 3.35 | (2.14–5.25) |
| CAP (every 1 quartile) | 2.05 | (1.43–2.93) | 1.89 | (1.31–2.72) | 1.87 | (1.29–2.70) |
| FLI (every 1 quartile) | 2.39 | (1.47–3.89) | 3.18 | (1.84–5.51) | 3.35 | (1.91–5.98.) |
| CAP (every 1 quartile) | 1.63 | (1.08–2.47) | 2.16 | (1.34–3.48) | 2.18 | (1.35–3.52) |
| Model 1 was adjusted for sex (in total population analysis) and age. Model 2 comprises model 1 plus FIB-4 score. MetS – metabolic syndrome; OR – odds ratio; CI – confidence interval; FLI – fatty liver index; CAP – controlled attenuation parameter; FIB-4 – fibrosis-4. # We combined the MetS stages C and D into 1 group because of the small number of participants in the MetS stage D in our cohort. | ||||||